Omada Health, Inc. (OMDA) Price & Analysis

Compare

140 Followers

OMDA Stock Chart & Stats

$15.65

-$4.40(-19.47%)

At close: Jun 10 4:00 PM EDT

$15.65

-$4.40(-19.47%)

Day’s Range― - ―

52-Week Range$14.14 - $28.40

Previous Close$18.29

Volume2.54M

Average Volume (3M)958.97K

Market Cap

$906.26M

Enterprise Value$1.08B

Total Cash (Recent Filing)$198.63M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta2.72

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding57,908,047

10 Day Avg. Volume1,570,102

30 Day Avg. Volume958,968

Financial Highlights & Ratios

PEG Ratio0.91

Price to Book (P/B)19.84

Price to Sales (P/S)7.55

P/FCF Ratio-33.70

Enterprise Value/Market Cap1.19

Enterprise Value/Revenue5.86

Enterprise Value/Gross Profit9.23

Enterprise Value/Ebitda-92.22

Forecast

1Y Price Target

$29.14

Price Target Upside86.20% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

EPS Forecast (FY)-0.03

Revenue Forecast (FY)$253.34M

Bulls Say, Bears Say

Bulls Say

Financial PerformanceOmada reached EBITDA profitability in Q3'25, five quarters ahead of initial estimates.

Growth OpportunitiesA large under-penetrated TAM, recent roll-out of an enhanced GLP-1 companion program, AI investments, and increasing cross-selling momentum provides significant runway for continued 20%+ revenue growth and expanding margins.

Market ExpansionOMDA currently has relationships with insurers covering ~10% of the commercial and Medicare Advantage markets, leaving a large opportunity to continue signing new payers.

Bears Say

Omada Health, Inc. News

Omada Health initiated with an Outperform at BMO Capital

BMO Capital initiated coverage of Omada Health (OMDA) with an Outperform rating and $27 price target A large...

29d ago

OMDA

Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Omada Health, Inc.. The associated price...

24d ago

OMDA

Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities

Omada Health, Inc. (OMDA) has received a new Buy rating, initiated by BMO Capital analyst, . BMO Capital’s...

29d ago

OMDA

Omada Health Reports Strong Growth and Innovation

Omada Health, Inc. (($OMDA)) has held its Q3 earnings call. Read on for the main highlights of the...

1M ago

OMDA

Omada Health price target raised to $32 from $30 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Omada Health (OMDA) to $32 from $30 and keeps an...

1M ago

OMDA

Omada Health price target raised to $28 from $27 at Evercore ISI

Evercore ISI raised the firm’s price target on Omada Health (OMDA) to $28 from $27 and keeps an...

1M ago

OMDA

Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating

Analyst Richard Close of Canaccord Genuity maintained a Buy rating on Omada Health, Inc., with a price target...

1M ago

OMDA

Omada Health, Inc.: Strong Market Position and Growth Potential Drive Buy Rating

Ryan MacDonald, an analyst from Needham, reiterated the Buy rating on Omada Health, Inc.. The associated price target...

1M ago

OMDA

Omada Health price target raised to $29 from $28 at Barclays

Barclays analyst Saket Kalia raised the firm’s price target on Omada Health (OMDA) to $29 from $28 and...

1M ago

OMDA

Omada Health Reports Strong Q3 2025 Growth

Omada Health, Inc. ( ($OMDA) ) has released its Q3 earnings. Here is a breakdown of the information...

1M ago

OMDA

Omada Health announces GLP-1 prescribing capability

Omada Health (OMDA) announced the planned launch of its prescribing capability, adding an option for prescribing and medication...

1M ago

OMDA

Omada Health reports Q3 EPS (6c), consensus (7c)

Reports Q3 revenue $68.03M, consensus $61.22M. Reports total members of 831,000, up 53%. “Our third quarter results demonstrate...

1M ago

OMDA

Omada Health raises FY25 revenue view to $251.5M-$254.5M from $235M-$241M

Consensus $238.89M. Raises FY25 adjusted EBITDA view to breakeven to loss of $2M from loss of $5M-$9M. Published...

1M ago

OMDA

Omada Health to present RWE on behavior change program at ObesityWeek

Omada Health (OMDA) will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada’s behavior change...

1M ago

OMDA

OMDA FAQ

What was Omada Health, Inc.’s price range in the past 12 months?

Omada Health, Inc. lowest stock price was $14.14 and its highest was $28.40 in the past 12 months.

What is Omada Health, Inc.’s market cap?

Omada Health, Inc.’s market cap is $906.26M.

When is Omada Health, Inc.’s upcoming earnings report date?

Omada Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 238 days.

How were Omada Health, Inc.’s earnings last quarter?

Omada Health, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.079 by $0.019.

Is Omada Health, Inc. overvalued?

According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Omada Health, Inc. pay dividends?

Omada Health, Inc. does not currently pay dividends.

What is Omada Health, Inc.’s EPS estimate?

Omada Health, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Omada Health, Inc. have?

Omada Health, Inc. has 57,908,047 shares outstanding.

What happened to Omada Health, Inc.’s price movement after its last earnings report?

Omada Health, Inc. reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.079. Following the earnings report the stock price went down -7.133%.

Which hedge fund is a major shareholder of Omada Health, Inc.?

Currently, no hedge funds are holding shares in OMDA

Omada Health, Inc. Stock Smart Score

Neutral

Company Description

Omada Health, Inc.

Omada Health, Inc. is a digital health company focused on chronic disease prevention and management. Founded in 2011, the company operates primarily in the healthcare technology sector, offering evidence-based programs aimed at helping individuals manage conditions such as diabetes, hypertension, and obesity. Omada's core products include a digital platform that provides personalized health coaching, connected devices, and digital therapeutics, all designed to improve health outcomes and support sustainable behavior change.

Omada Health, Inc. (OMDA) Earnings & Revenues

Historic Earnings Reports

OMDA Company Deck

OMDA Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects strong growth in membership and revenue, driven by innovation and operational efficiency. Despite some concerns about cash flow due to debt repayment and reliance on the GLP-1 market segment, the overall financial and strategic outlook remains positive.View all OMDA earnings summaries

OMDA Stock 12 Month Forecast

Average Price Target

$29.14

▲(86.20% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","33":"$33","20.25":"$20.3","24.5":"$24.5","28.75":"$28.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$29.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,20.25,24.5,28.75,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.73,19.75076923076923,20.771538461538462,21.79230769230769,22.813076923076924,23.833846153846153,24.854615384615386,25.875384615384615,26.896153846153844,27.916923076923077,28.93769230769231,29.95846153846154,30.979230769230767,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.73,19.53076923076923,20.33153846153846,21.13230769230769,21.933076923076925,22.733846153846155,23.534615384615385,24.335384615384616,25.136153846153846,25.93692307692308,26.737692307692306,27.53846153846154,28.33923076923077,{"y":29.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.73,19.366153846153846,20.002307692307692,20.638461538461538,21.274615384615384,21.91076923076923,22.546923076923076,23.183076923076925,23.81923076923077,24.455384615384617,25.091538461538462,25.72769230769231,26.363846153846154,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.6,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >